2016 Annual Meeting | Redefining Parkinson's Disease: Challenging the Past and Preparing For the Future
06:30 AM - 07:00 AM |
PD: A Disorder of Multiple Systems?
Jennifer G. Goldman, MD, MS, FAAN |
|
07:00 AM - 07:30 AM |
PD: A Disorder with Multiple Etiologies?
Ronald Postuma, MD |
|
07:30 AM - 08:00 AM |
PD: A Disorder that Requires Multiple Therapeutic Approaches...
Jennifer G. Goldman, MD, MS, FAAN |
|
08:00 AM - 08:30 AM |
PD: A Disorder in Need of Redefinition!
Ronald Postuma, MD |
Ronald Postuma, MD | Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH. |
Jennifer G. Goldman, MD, MS, FAAN | Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation. |